Home | Archives | Products | About | Contact | FAQ |
New User? Sign Up | Sign In
insider trading reports Form 4 Filings Insider Buys Significant Buys Penny Stocks
Insider Buying
Insider Sales
Insider Buy Sell Ratios Stock Options Insider Trading
Stock Screener
Insider Trading
Graph View
Insider Watch

Insider Trading - Denali Therapeutics Inc. (DNLI)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
DNLI Insider Trading Transactions for Denali Therapeutics Inc.
Goto page 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-02-08
Sale
2019-02-12
6:30 pm
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
7,500 $19.08 $143,089 667,589
(Direct
Indirect)
View
2019-02-01
Sale
2019-02-05
6:28 pm
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
17,500 $18.72 $327,589 142,615
(Direct
Indirect)
View
2019-02-01
Sale
2019-02-05
6:27 pm
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
18,334 $18.72 $343,300 2,646,588
(Direct
Indirect)
View
2019-01-09
Sale
2019-01-11
5:11 pm
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
7,500 $20.37 $152,750 675,089
(Direct
Indirect)
View
2019-01-02
Sale
2019-01-04
6:54 pm
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
14,502 $19.55 $283,506 143,515
(Direct
Indirect)
View
2019-01-02
Sale
2019-01-04
6:52 pm
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
18,333 $19.43 $356,288 2,665,921
(Direct
Indirect)
View
2018-12-10
Sale
2018-12-12
5:27 pm
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
7,500 $20.4 $153,000 682,589
(Direct
Indirect)
View
2018-12-03
Sale
2018-12-06
5:08 pm
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
17,500 $18.45 $322,834 148,790
(Direct
Indirect)
View
2018-11-27
Sale
2018-12-06
5:06 pm
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
18,333 $18.43 $337,938 2,689,304
(Direct
Indirect)
View
2018-11-15
Sale
2018-11-19
5:31 pm
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
17,500 $18.07 $316,157 165,890
(Direct
Indirect)
View
2018-11-13
Sale
2018-11-15
6:13 pm
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
18,334 $18.09 $331,664 2,742,892
(Direct
Indirect)
View
2018-10-01
Sale
2018-10-03
6:01 pm
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
18,333 $21.72 $398,193 2,747,638
(Direct
Indirect)
View
2018-10-01
Sale
2018-10-03
5:59 pm
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
17,500 $21.72 $380,100 183,390
(Direct
Indirect)
View
2018-09-04
Sale
2018-09-06
5:27 pm
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
17,500 $19.05 $333,375 200,890
(Direct
Indirect)
View
2018-09-04
Sale
2018-09-06
5:25 pm
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
18,333 $19.06 $349,427 2,765,971
(Direct
Indirect)
View
2018-08-29
Sale
2018-08-31
5:44 pm
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
17,500 $18.04 $315,700 218,390
(Direct
Indirect)
View
2018-08-29
Sale
2018-08-31
5:41 pm
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
18,334 $18.05 $330,929 2,784,304
(Direct
Indirect)
View
2017-12-12
Purchase
2017-12-14
4:09 pm
Denali Therapeutics Inc. DNLI BRATTON DOUGLAS K
AKDL L.P.
Neuro Line Partners LP
Crestline SI (GP) L.P.
Crestline Investors Inc.
Bratton Capital Management L.P.
Bratton Capital Inc.
Crestline Management LP
10% Owner
275,000 $18 $4,950,000 19,462,500
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-02-07
Option Award
2019-02-11
5:59 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
17,000 $0 136,000
(Direct)
View
2019-02-07
Option Award
2019-02-11
5:59 pm
N/A
2029-02-06
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
136,000 $17.99 136,000
(Direct)
View
2019-02-07
Option Award
2019-02-11
5:57 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
17,000 $0 136,000
(Direct)
View
2019-02-07
Option Award
2019-02-11
5:57 pm
N/A
2029-02-06
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
136,000 $17.99 136,000
(Direct)
View
2019-02-07
Option Award
2019-02-11
5:56 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Krognes Steve E.
CFO
17,000 $0 136,000
(Direct)
View
2019-02-07
Option Award
2019-02-11
5:56 pm
N/A
2029-02-06
Denali Therapeutics Inc. DNLI Krognes Steve E.
CFO
136,000 $17.99 136,000
(Direct)
View
2019-02-08
Option Award
2019-02-11
5:54 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
11,031 $0 281,600
(Direct)
View
2019-02-08
Option Award
2019-02-11
5:54 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
35,200 $0 281,600
(Direct)
View
2019-02-08
Option Award
2019-02-11
5:54 pm
N/A
2029-02-07
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
281,600 $18.13 281,600
(Direct)
View
2019-02-01
Exercise
2019-02-05
6:28 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
5,775 $5.28 142,615
(Direct)
View
2019-02-01
Exercise
2019-02-05
6:28 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
730 $5.28 142,615
(Direct)
View
2019-02-01
Exercise
2019-02-05
6:28 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
3,139 $5.28 142,615
(Direct)
View
2019-02-01
Exercise
2019-02-05
6:28 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
7,856 $5.28 142,615
(Direct)
View
2019-02-01
Exercise
2019-02-05
6:28 pm
N/A
2026-07-01
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
5,775 $5.28 142,615
(Direct)
View
2019-02-01
Exercise
2019-02-05
6:28 pm
N/A
2026-07-01
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
730 $5.28 142,615
(Direct)
View
2019-02-01
Exercise
2019-02-05
6:28 pm
N/A
2027-03-07
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
3,139 $5.28 142,615
(Direct)
View
2019-02-01
Exercise
2019-02-05
6:28 pm
N/A
2027-03-07
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
7,856 $5.28 142,615
(Direct)
View
2019-01-02
Exercise
2019-01-04
6:54 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
5,775 $5.28 143,515
(Direct)
View
2019-01-02
Exercise
2019-01-04
6:54 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
5,950 $5.28 143,515
(Direct)
View
2019-01-02
Exercise
2019-01-04
6:54 pm
N/A
2026-07-01
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
5,775 $5.28 143,515
(Direct)
View
2019-01-02
Exercise
2019-01-04
6:54 pm
N/A
2026-07-01
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
5,950 $5.28 143,515
(Direct)
View
2018-11-27
Gift
2018-12-06
5:06 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
40,000 $0 2,689,304
(Indirect)
View
2018-11-06
Option Award
2018-11-08
5:37 pm
N/A
2028-11-05
Denali Therapeutics Inc. DNLI Cook Jennifer E.
Director
50,044 $17.08 50,044
(Direct)
View
2018-10-02
Exercise
2018-10-03
5:58 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
1,184 $5.28 685,089
(Direct)
View
2018-10-02
Exercise
2018-10-03
5:58 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
5,859 $9.6 685,089
(Direct)
View
2018-10-02
Exercise
2018-10-03
5:58 pm
N/A
2027-03-07
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
1,184 $5.28 685,089
(Direct)
View
2018-10-02
Exercise
2018-10-03
5:58 pm
N/A
2027-08-21
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
5,859 $9.6 685,089
(Direct)
View
2018-08-20
Option Award
2018-08-22
5:45 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
11,286 $0 11,286
(Direct)
View
2018-08-20
Option Award
2018-08-22
5:43 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
11,286 $0 11,286
(Direct)
View
2018-08-20
Option Award
2018-08-22
5:42 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Krognes Steve E.
CFO
11,286 $0 11,286
(Direct)
View
2018-06-22
Exercise
2018-06-26
5:38 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
5,918 $5.28 685,089
(Direct)
View
2018-06-22
Exercise
2018-06-26
5:38 pm
N/A
2027-03-07
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
5,918 $5.28 685,089
(Direct)
View
2018-06-13
Option Award
2018-06-15
6:31 pm
N/A
2028-06-12
Denali Therapeutics Inc. DNLI NELSEN ROBERT
Director, 10% Owner
27,830 $18.92 27,830
(Direct)
View
2018-06-13
Option Award
2018-06-15
6:30 pm
N/A
2028-06-12
Denali Therapeutics Inc. DNLI Tessier-Lavigne Marc
Director
27,830 $18.92 27,830
(Direct)
View
2018-06-13
Option Award
2018-06-15
6:29 pm
N/A
2028-06-12
Denali Therapeutics Inc. DNLI FLATLEY JAY T
Director
27,830 $18.92 27,830
(Direct)
View
2018-06-13
Option Award
2018-06-15
6:28 pm
N/A
2028-06-12
Denali Therapeutics Inc. DNLI Schenkein David P
Director
27,830 $18.92 27,830
(Direct)
View
2018-06-13
Option Award
2018-06-15
6:27 pm
N/A
2028-06-12
Denali Therapeutics Inc. DNLI Cole Douglas G.
Director
27,830 $18.92 27,830
(Direct)
View
2018-06-13
Option Award
2018-06-15
6:27 pm
N/A
2028-06-12
Denali Therapeutics Inc. DNLI SATO VICKI L
Director
27,830 $18.92 27,830
(Direct)
View
2018-03-16
Option Award
2018-03-20
6:29 pm
N/A
2028-03-15
Denali Therapeutics Inc. DNLI Klein Peter S
Director
37,954 $21.53 37,954
(Direct)
View
2018-02-26
Option Award
2018-02-28
7:57 pm
N/A
2028-02-25
Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer
180,000 $22.16 180,000
(Direct)
View
2018-02-26
Option Award
2018-02-28
7:56 pm
N/A
2028-02-25
Denali Therapeutics Inc. DNLI Krognes Steve E.
CFO
180,000 $22.16 180,000
(Direct)
View
2018-02-26
Option Award
2018-02-28
7:55 pm
N/A
2028-02-25
Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO
180,000 $22.16 180,000
(Direct)
View
2017-12-13
Option Award
2018-02-28
7:53 pm
N/A
N/A
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
5 $20.47 2,802,638
(Direct)
View
2017-12-13
Option Award
2018-02-28
7:53 pm
N/A
2028-02-25
Denali Therapeutics Inc. DNLI Watts Ryan J.
CEO
300,000 $22.16 2,802,638
(Direct)
View
2017-12-12
Conversion
2017-12-14
4:09 pm
N/A
N/A
Denali Therapeutics Inc. DNLI BRATTON DOUGLAS K
AKDL L.P.
Neuro Line Partners LP
Crestline SI (GP) L.P.
Crestline Investors Inc.
Bratton Capital Management L.P.
Bratton Capital Inc.
Crestline Management LP
10% Owner
14,499,999 $0 19,462,500
(Indirect)
View
2017-12-12
Conversion
2017-12-14
4:09 pm
N/A
N/A
Denali Therapeutics Inc. DNLI BRATTON DOUGLAS K
AKDL L.P.
Neuro Line Partners LP
Crestline SI (GP) L.P.
Crestline Investors Inc.
Bratton Capital Management L.P.
Bratton Capital Inc.
Crestline Management LP
10% Owner
2,500,000 $0 19,462,500
(Indirect)
View
2017-12-12
Conversion
2017-12-14
4:09 pm
N/A
N/A
Denali Therapeutics Inc. DNLI BRATTON DOUGLAS K
AKDL L.P.
Neuro Line Partners LP
Crestline SI (GP) L.P.
Crestline Investors Inc.
Bratton Capital Management L.P.
Bratton Capital Inc.
Crestline Management LP
10% Owner
1,875,000 $0 19,462,500
(Indirect)
View
2017-12-12
Conversion
2017-12-14
4:09 pm
N/A
N/A
Denali Therapeutics Inc. DNLI BRATTON DOUGLAS K
AKDL L.P.
Neuro Line Partners LP
Crestline SI (GP) L.P.
Crestline Investors Inc.
Bratton Capital Management L.P.
Bratton Capital Inc.
Crestline Management LP
10% Owner
743,599 $0 19,462,500
(Indirect)
View
2017-12-12
Conversion
2017-12-14
4:09 pm
N/A
N/A
Denali Therapeutics Inc. DNLI BRATTON DOUGLAS K
AKDL L.P.
Neuro Line Partners LP
Crestline SI (GP) L.P.
Crestline Investors Inc.
Bratton Capital Management L.P.
Bratton Capital Inc.
Crestline Management LP
10% Owner
128,200 $0 19,462,500
(Indirect)
View
2017-12-12
Conversion
2017-12-14
4:09 pm
N/A
N/A
Denali Therapeutics Inc. DNLI BRATTON DOUGLAS K
AKDL L.P.
Neuro Line Partners LP
Crestline SI (GP) L.P.
Crestline Investors Inc.
Bratton Capital Management L.P.
Bratton Capital Inc.
Crestline Management LP
10% Owner
240,000 $0 19,462,500
(Indirect)
View
2017-12-12
Conversion
2017-12-14
4:09 pm
N/A
N/A
Denali Therapeutics Inc. DNLI BRATTON DOUGLAS K
AKDL L.P.
Neuro Line Partners LP
Crestline SI (GP) L.P.
Crestline Investors Inc.
Bratton Capital Management L.P.
Bratton Capital Inc.
Crestline Management LP
10% Owner
14,499,999 $0 19,462,500
(Indirect)
View
2017-12-12
Conversion
2017-12-14
4:09 pm
N/A
N/A
Denali Therapeutics Inc. DNLI BRATTON DOUGLAS K
AKDL L.P.
Neuro Line Partners LP
Crestline SI (GP) L.P.
Crestline Investors Inc.
Bratton Capital Management L.P.
Bratton Capital Inc.
Crestline Management LP
10% Owner
2,500,000 $0 19,462,500
(Indirect)
View
2017-12-12
Conversion
2017-12-14
4:09 pm
N/A
N/A
Denali Therapeutics Inc. DNLI BRATTON DOUGLAS K
AKDL L.P.
Neuro Line Partners LP
Crestline SI (GP) L.P.
Crestline Investors Inc.
Bratton Capital Management L.P.
Bratton Capital Inc.
Crestline Management LP
10% Owner
1,875,000 $0 19,462,500
(Indirect)
View
2017-12-12
Conversion
2017-12-14
4:09 pm
N/A
N/A
Denali Therapeutics Inc. DNLI BRATTON DOUGLAS K
AKDL L.P.
Neuro Line Partners LP
Crestline SI (GP) L.P.
Crestline Investors Inc.
Bratton Capital Management L.P.
Bratton Capital Inc.
Crestline Management LP
10% Owner
743,599 $0 19,462,500
(Indirect)
View
2017-12-12
Conversion
2017-12-14
4:09 pm
N/A
N/A
Denali Therapeutics Inc. DNLI BRATTON DOUGLAS K
AKDL L.P.
Neuro Line Partners LP
Crestline SI (GP) L.P.
Crestline Investors Inc.
Bratton Capital Management L.P.
Bratton Capital Inc.
Crestline Management LP
10% Owner
128,200 $0 19,462,500
(Indirect)
View
2017-12-12
Conversion
2017-12-14
4:09 pm
N/A
N/A
Denali Therapeutics Inc. DNLI BRATTON DOUGLAS K
AKDL L.P.
Neuro Line Partners LP
Crestline SI (GP) L.P.
Crestline Investors Inc.
Bratton Capital Management L.P.
Bratton Capital Inc.
Crestline Management LP
10% Owner
240,000 $0 19,462,500
(Indirect)
View
Goto page 0, 1, Next